tirzepatide indications fda The long awaited twincretin was just approved on Friday for type 2 diabetes! 💊 Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP FDA Approves Mounjaro (tirzepatide) Injection

Its cheap

Studies have shown that long-term use of GLP-1 medications is generally safe and effective for both diabetes management and weight loss

Note: Swiss Chems received an FDA warning letter on December 10, 2024 for selling unapproved GLP-1-class drugs including semaglutide and retatrutide one of four simultaneous warning letters issued to grey-market peptide vendors that day

Patient-First Experience: From your first consultation to ongoing progress tracking, we tailor everything to your body and your goals

In 2025, the European Medicines Agency recommended updating semaglutide product information to include NAION as a very rare side effect